Notably, downregulation of MYC is not a general feature of prostate cancer growth arrest, as the highly active chemotherapy agent docetaxel did induce growth arrest of LNCaP cells but did not cause downregulation of MYC (Supplemental Figure 3, A and B). Here, MYC is linked to prostate carcinoma.